EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Convergent mutation trajectories convert functional self-tolerance in IGHV4-34 B cells to genetic tolerance encoded in the antibody

Christopher J Jara, Sherin Zachariah, Katherine J L Jackson, Timothy J Peters, Etienne Masle-Farquhar, Deborah L Burnett iD, Eric Lam, Megan Faulks, Amanda Russell, Lisa Miosge, Stewart Smith, David C Tscharke iD und 3 weitere

Proceedings of the National Academy of Sciences · 2025

DOI: 10.1073/pnas.2522257122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von Christopher J Jara und 14 weiteren Autor:innen. Beteiligte Einrichtung: Garvan Institute of Medical Research, Darlinghurst, NSW 2010, Australia. Hauptthemen laut MEDLINE: B-Lymphocytes, Mutation, Self Tolerance, Immunoglobulin Heavy Chains. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: DHAC | National Health and Medical Research Council (NHMRC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Preventing autoantibody secretion by rendering self-reactive B cells functionally silent through clonal anergy has long posed the question of why fill the circulating B cell repertoire with cells that cannot secrete antibody? Here we address this question from the perspective of B cells that comprise 5 to 10% of the human circulating repertoire, expressing self-reactive surface immunoglobulins employing the IGHV4-34 heavy chain variable element. Using gene targeting to construct mice expressing a representative human IGHV4-34 antibody on the surface of many B cells, we show these cells are prevented from autoantibody secretion by B cell clonal anergy marked by downregulation of surface IgM, induction of tolerance-response mRNAs, and exclusion from the marginal zone and B1 cell subsets. This functionally tolerant state is overridden when the IGHV4-34 B cells cross-react with a virus, which stimulates the self-reactive B cells to hypermutate in germinal centers. Within 16 d of infection, 99% of daughter cells have acquired one of five heavy chain mutations that diminish binding to self but preserve virus binding, and 33% had combined 2 or 3 of these mutations to make their antibodies genetically self-tolerant and virus specific. These results demonstrate, from the perspective of a pathologically important human autoantibody class and the world’s most successful virus vaccine, how human antibody specificity is sculpted in the progeny of anergic B cells to yield antibodies that bind a virus but not self.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

B-LymphocytesMutationSelf ToleranceImmunoglobulin Heavy ChainsImmunoglobulin Variable RegionAnimalsMiceHumansAutoantibodiesClonal AnergyImmunoglobulin MMice, Transgenic

Stichwörter der Autor:innen

anergyantibody specificitycold agglutinin diseasesomatic hypermutationvaccinia virus

Substanzen

Immunoglobulin Heavy ChainsAutoantibodiesImmunoglobulin Variable RegionImmunoglobulin M

Autor:innen und Institutionen

  • Garvan Institute of Medical Research, Darlinghurst, NSW 2010, Australia.
  • St. Vincent's Clinical School, Faculty of Medicine, University of New South Wales Sydney, Sydney, NSW 2052, Australia.
  • John Curtin School of Medical Research, The Australian National University, Canberra, ACT 2601, Australia.
  • School of Biomedical Sciences, University of New South Wales Sydney, Sydney, NSW 2052, Australia.
  • Cellular Genomics Futures Institute, University of New South Wales Sydney, Sydney, NSW 2052, Australia.
  • Westmead Institute for Medical Research, University of Sydney, Westmead, NSW 2145, Australia.

ORCID-Profile: Deborah L Burnett, David C Tscharke, Christopher C Goodnow, Joanne H Reed

Förderung

  • DHAC | National Health and Medical Research Council (NHMRC)

Zitieren

APA

Jara, C. J., Zachariah, S., Jackson, K. J. L., Peters, T. J., Masle-Farquhar, E., Burnett, D. L., Lam, E., Faulks, M., Russell, A., Miosge, L., Smith, S., Tscharke, D. C., Brink, R., Goodnow, C. C., & Reed, J. H. (2025). Convergent mutation trajectories convert functional self-tolerance in IGHV4-34 B cells to genetic tolerance encoded in the antibody. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2522257122

Vancouver

Jara CJ, Zachariah S, Jackson KJL, Peters TJ, Masle-Farquhar E, Burnett DL, et al. Convergent mutation trajectories convert functional self-tolerance in IGHV4-34 B cells to genetic tolerance encoded in the antibody. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2522257122

BibTeX
@article{Jara2025,
  author = {Jara, Christopher J and Zachariah, Sherin and Jackson, Katherine J L and Peters, Timothy J and Masle-Farquhar, Etienne and Burnett, Deborah L and Lam, Eric and Faulks, Megan and Russell, Amanda and Miosge, Lisa and Smith, Stewart and Tscharke, David C and Brink, Robert and Goodnow, Christopher C and Reed, Joanne H},
  title = {Convergent mutation trajectories convert functional self-tolerance in IGHV4-34 B cells to genetic tolerance encoded in the antibody},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2025},
  doi = {10.1073/pnas.2522257122}
}
Kostenlos starten →